Intravesical instillation of SCH 58500 transfers the p53 gene in patients with invasive bladder cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1330, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer

By Yutkin Vladimir Chin Joseph

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 251-260

Informa Healthcare

Access to resources Recommend Favorite

The Correlation of Tissue p53 Protein Overexpression and p53 Antigen in Serum of Patients with Bladder Cancer

By Gopi Kishore M. Hamid Arif Dwivedi U.S. Tandon Vipul Mahmood Mufti Singh Harbans Singh P.B.

UroOncology, Vol. 2, Iss. 3, 2003-07 ,pp. : 121-128

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Intravesical therapy for bladder cancer

By Williams Steve K Hoenig David M Ghavamian Reza Soloway Mark

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 6, 2010-04 ,pp. : 947-958

Informa Healthcare

Access to resources Recommend Favorite

Intravesical valrubicin for bladder cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 268, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Intravesical Therapy of Superficial Bladder Cancer

Current Pharmaceutical Design, Vol. 6, Iss. 3, 2000-02 ,pp. : 345-359

Bentham Science Publishers

Access to resources Recommend Favorite